UCB7853
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for UCB7853, covering 2024-07-08 to 2024-07-08. Get the full timeline:
Most recent: Clinical Trial Update: A Safety and Pharmacokinetics Study of UCB7853 in Healthy Study Participants and Study Participants With Parkinson's Disease (PD) [Phase 1]